title: Understanding nontuberculous mycobacterial lung disease: it's been a long time coming.
abstract: With a surprising predictability, most studies and reviews addressing therapy for nontuberculous mycobacterial (NTM) lung disease either start or end by mentioning the paucity of data from randomized and controlled trials. That is a legitimate criticism for NTM lung disease therapy, but it also somehow seems to influence attitudes toward all aspects of NTM investigation. Certainly the study of NTM diseases in general and NTM lung disease in particular is a recent development. Previously, NTM were viewed as minor, if inconvenient, pathogens similar toMycobacterium tuberculosis. However, over the last three decades, NTM have emerged as increasingly important pathogens that are clearly different compared with tuberculosis. Although there has been frustratingly slow progress in the treatment of NTM diseases, in contrast there has unquestionably been impressive progress in almost every other realm of investigation into NTM disease. Our understanding of NTM lung disease a) pathophysiology, including mechanisms of organism acquisition, b) epidemiology, including estimates of disease prevalence, c) mycobacteriology, including application of molecular laboratory techniques and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, and d) even treatment strategies, including the recognition of innate drug resistance mechanisms, has immeasurably and permanently changed and advanced the landscape for NTM lung disease. It is no longer necessary to apologize for the state of NTM lung disease knowledge and understanding, but rather it is time to recognize the great distance we have travelled over the last 30 years.
authors.affiliation: University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
authors.forename: David E
authors.initials: DE
authors.lastname: Griffith
authors.affiliation: Mayo Clinic, Pulmonary Disease and Critical Care Medicine, Rochester, Minnesota, USA.
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Aksamit
keywords: Nontuberculous; lung disease; mycobacterial